<abstract xmlns="http://www.w3.org/1999/xhtml"><p> Background and objectives: This review focuses on three areas, basic acid-base physiology especially concerning hydrogen ion balance, development of acidosis in chronic kidney disease (CKD), and the consequences of acidosis. We highlight what is well established, what is less certain, and what is unknown. Method and results: The literature on acidosis in CKD were searched from 2004 to 2010 utilizing PubMed, Google Scholar, and Ovid to augment the classic work on acid base physiology over the past three decades. The original research in endogenous acid production and net acid excretion were reviewed. Touching upon the development of metabolic acidosis in CKD, we focused on the consequences of chronic metabolic acidosis on growth and other important variables. Finally, we recognize the significant issue of patients’ medical non-compliance and presented treatment strategy to counter this problem. Conclusion: The correction of acidosis in chronic kidney disease needs no advocacy. The case is made conclusively. Patient non-compliance because of the medication that needs to be taken several times a day is a problem, requiring due diligence.</p></abstract>

Background and objectives: This review focuses on three areas, basic acid-base physiology especially concerning hydrogen ion balance, development of acidosis in chronic kidney disease (CKD), and the consequences of acidosis. We highlight what is well established, what is less certain, and what is unknown. Method and results: The literature on acidosis in CKD were searched from 2004 to 2010 utilizing PubMed, Google Scholar, and Ovid to augment the classic work on acid base physiology over the past three decades. The original research in endogenous acid production and net acid excretion were reviewed. Touching upon the development of metabolic acidosis in CKD, we focused on the consequences of chronic metabolic acidosis on growth and other important variables. Finally, we recognize the significant issue of patients’ medical non-compliance and presented treatment strategy to counter this problem. Conclusion: The correction of acidosis in chronic kidney disease needs no advocacy. The case is made conclusively. Patient non-compliance because of the medication that needs to be taken several times a day is a problem, requiring due diligence.

The role of metabolic acidosis in chronic kidney diseases

Asian Biomedicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

{"article-title":"The role of metabolic acidosis in chronic kidney diseases"}

Background and objectives: This review focuses on three areas, basic acid-base physiology especially concerning hydrogen ion balance, development of acidosis...

The role of metabolic acidosis in chronic kidney diseases

Online veröffentlicht: 13. Apr. 2018

Seitenbereich: 367 - 372

DOI: https://doi.org/10.2478/abm-2010-0045

Schlüsselwörter
Bicarbonate therapy, chronic kidney disease, growth retardation, metabolic acidosis, net acid balance, non-compliance

© 2018

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

The role of metabolic acidosis in chronic kidney diseases

Online veröffentlicht: 13. Apr. 2018

Seitenbereich: 367 - 372

DOI: https://doi.org/10.2478/abm-2010-0045

SchlüsselwörterBicarbonate therapy, chronic kidney disease, growth retardation, metabolic acidosis, net acid balance, non-compliance

© 2018

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Schlüsselwörter
Bicarbonate therapy, chronic kidney disease, growth retardation, metabolic acidosis, net acid balance, non-compliance